Literature DB >> 19787412

Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results.

P K Chowbey1, K Dhawan, R Khullar, A Sharma, V Soni, M Baijal, T Mittal.   

Abstract

BACKGROUND: Obesity has been observed to be on the rise in the Indian subcontinent. We report our early experience with the laparoscopic sleeve gastrectomy (LSG) for treating morbid obesity in the Indian population along with description of the surgical technique.
METHODS: The data of 75 patients who underwent LSG for the treatment of morbid obesity at the Minimal Access, Metabolic and Bariatric Surgery Centre, Sir Ganga Ram Hospital, Delhi, from November 2006 to February 2009, were retrospectively reviewed from prospective database. The gastric sleeve is created laparoscopically using sequential firings of a linear stapling device applied alongside a 36-Fr calibrating bougie. The data collected included age, gender, initial body mass index (BMI) and excess weight, the co-morbidity status, and preoperative investigations. Perioperative parameters and follow-up details [weight, BMI, excess weight loss (%EWL), resolution of co-morbidities, and postoperative investigations] were noted.
RESULTS: All procedures were completed laparoscopically. There was no major procedure-related morbidity. Hemorrhage requiring blood transfusion was observed in four patients. One patient died at 2 weeks postoperatively due to pulmonary embolism. There was a steady rise in %EWL from 31.2% at 3 months to 52.3% at 6 months, 59.13% at 1 year, and 65% at 2 years. Type II diabetes was resolved in 81.2%, hypertension in 93.75%, and dyslipidemia in 85% at 1 year.
CONCLUSION: Although long-term results are necessary to determine the benefits of the procedure, early results indicate that LSG may be a safe and feasible option for treating the morbidly obese patients.

Entities:  

Mesh:

Year:  2009        PMID: 19787412     DOI: 10.1007/s11695-009-9973-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  31 in total

1.  Overweight and obesity worldwide now estimated to involve 1.7 billion people.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

3.  Laparoscopic biliopancreatic diversion with a duodenal switch for morbid obesity: a feasibility study in pigs.

Authors:  J de Csepel; S Burpee; G Jossart; V Andrei; Y Murakami; S Benavides; M Gagner
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2001-04       Impact factor: 1.878

4.  Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers.

Authors:  Franz X Felberbauer; Felix Langer; Soheila Shakeri-Manesch; Elisabeth Schmaldienst; Mathias Kees; Stephan Kriwanek; Manfred Prager; Gerhard Prager
Journal:  Obes Surg       Date:  2008-04-08       Impact factor: 4.129

Review 5.  Current estimates of the economic cost of obesity in the United States.

Authors:  A M Wolf; G A Colditz
Journal:  Obes Res       Date:  1998-03

6.  Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.

Authors:  Gianfranco Silecchia; Cristian Boru; Alessandro Pecchia; Mario Rizzello; Giovanni Casella; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

7.  Association of obesity with hiatal hernia and esophagitis.

Authors:  L J Wilson; W Ma; B I Hirschowitz
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

8.  Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results.

Authors:  Crystine M Lee; Paul T Cirangle; Gregg H Jossart
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 4.584

9.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

10.  Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity?

Authors:  Felix B Langer; Arthur Bohdjalian; Franz X Felberbauer; Edith Fleischmann; Mir A Reza Hoda; Bernhard Ludvik; Johannes Zacherl; Raimund Jakesz; Gerhard Prager
Journal:  Obes Surg       Date:  2006-02       Impact factor: 4.129

View more
  20 in total

1.  Reply to the Letter to the Editor Submitted by Michel Gagner (Publish with OBSU-D-15-00482).

Authors:  Scott A Shikora; Christine Brown Mahoney
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

2.  Our 1-year experience in laparoscopic sleeve gastrectomy.

Authors:  Ganesh Ramalingam; Cheng Kui Seng Anton
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

3.  An analysis of 1-3-year follow-up results of laparoscopic sleeve gastrectomy: an Indian perspective.

Authors:  Parmanand Prasad; Om Tantia; Nirmal Patle; Shashi Khanna; Bimalendu Sen
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

4.  Effects of Laparoscopic Sleeve Gastrectomy on Central Obesity and Metabolic Syndrome in Indian Adults- A Prospective Study.

Authors:  Pulkit Sethi; Manoj Thillai; Prabhdeep Singh Nain; Ashish Ahuja; Sudheer Othiyil Vayoth; Preetika Khurana
Journal:  J Clin Diagn Res       Date:  2017-01-01

Review 5.  Initial experience with laparoscopic sleeve gastrectomy by a novice bariatric team in an established bariatric center--a review of literature and initial results.

Authors:  Ashish Dey; Tarun Mittal; Vinod K Malik
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

6.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

8.  Chronic Renin-Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery.

Authors:  Guido Salvetti; Claudio Di Salvo; Giovanni Ceccarini; Antonio Abramo; Paola Fierabracci; Silvia Magno; Paolo Piaggi; Paolo Vitti; Ferruccio Santini
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

9.  Significant weight loss and rapid resolution of diabetes and dyslipidemia during short-term follow-up after laparoscopic sleeve gastrectomy.

Authors:  A Perathoner; A Weißenbacher; R Sucher; E Laimer; J Pratschke; R Mittermair
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

Review 10.  The effects of bougie caliber on leaks and excess weight loss following laparoscopic sleeve gastrectomy. Is there an ideal bougie size?

Authors:  Jonathan B Yuval; Yoav Mintz; Matan J Cohen; Avraham I Rivkind; Ram Elazary
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.